GSTM1 and anemia: The hemoglobin-to-creatinine ratio (Hb/Cr) serves as an integrated marker of anemia and renal dysfunction, both of which contribute to chronic inflammation and hemodynamic disturbances in ACS patients, thereby influencing prognosis [60,61].